Denali Therapeutics Inc (DNLI) Reports Full Year and Q4 2023 Financial Results
Highlights Strategic Progress and Clinical Developments
Source: yahoo.com
Stay updated with breaking news from Biogen Collaboration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Highlights Strategic Progress and Clinical Developments
ZURZUVAE™ approved as first-and-only oral treatment specifically indicated for adults with postpartum depression and on-track for planned launch in the fourth quarter of 2023 shortly after DEA...